Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Press South Dakota.
Press releases published on March 6, 2026
Mar. 6, 2026
Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.
Indeterminate
GlobeNewswire
Mar. 6, 2026
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Mar. 6, 2026
Revive Environmental Announces CEO Transition
Indeterminate
GlobeNewswire
Mar. 6, 2026
Quick Custom Intelligence and Maropost Power Real-Time Data at Enterprise Scale
Indeterminate
GlobeNewswire
Mar. 6, 2026
Mubite Introduces New Global Trading Platform Integration with Instant Funding Opportunities
Indeterminate
GlobeNewswire
Mar. 6, 2026
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Mar. 6, 2026
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Mar. 6, 2026
Crescent Biopharma Announces Grants of Inducement Awards
Indeterminate
GlobeNewswire
Mar. 6, 2026
UPDATE -- ToltIQ Selected by H.I.G. Capital for Firm-Wide Due Diligence Deployment
Indeterminate
GlobeNewswire
Mar. 6, 2026
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Mar. 6, 2026
Spyre Therapeutics Announces Grants of Inducement Awards
Indeterminate
GlobeNewswire
Mar. 6, 2026
Wearable Devices Ltd. Announces 1-for-3 Reverse Stock Split
Indeterminate
GlobeNewswire
Mar. 6, 2026
CAMP4 to Participate in Upcoming Investor Conferences
Indeterminate
GlobeNewswire
Mar. 6, 2026
Galapagos Creates New Subscription Right Plan
Indeterminate
GlobeNewswire
Mar. 6, 2026
Galapagos creëert nieuw inschrijvingsrechtenplan
Indeterminate
GlobeNewswire
Mar. 6, 2026
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Mar. 6, 2026
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Mar. 6, 2026
Harvard Bioscience Announces Reverse Stock Split
Indeterminate
GlobeNewswire
Mar. 6, 2026
Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection
Indeterminate
GlobeNewswire
Mar. 6, 2026
Letter to Shareholders from CEO Dr. Ryan Saadi
Indeterminate
GlobeNewswire